141 related articles for article (PubMed ID: 27146385)
1. Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target.
Craig JK; Risler JK; Loesch KA; Dong W; Baker D; Barrett LK; Subramanian S; Samudrala R; Van Voorhis WC
J Biomol Screen; 2016 Aug; 21(7):695-700. PubMed ID: 27146385
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
Koseki Y; Kinjo T; Kobayashi M; Aoki S
Eur J Med Chem; 2013 Feb; 60():333-9. PubMed ID: 23314046
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydro-2-furanyl-2,4(1H,3H)-pyrimidinedione derivatives as novel antibacterial compounds against
Koseki Y; Kanetaka H; Tsunosaki J; Munier-Lehmann H; Aoki S
Int J Mycobacteriol; 2017; 6(1):61-69. PubMed ID: 28317807
[TBL] [Abstract][Full Text] [Related]
4. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R
J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site.
Mendes V; Green SR; Evans JC; Hess J; Blaszczyk M; Spry C; Bryant O; Cory-Wright J; Chan DS; Torres PHM; Wang Z; Nahiyaan N; O'Neill S; Damerow S; Post J; Bayliss T; Lynch SL; Coyne AG; Ray PC; Abell C; Rhee KY; Boshoff HIM; Barry CE; Mizrahi V; Wyatt PG; Blundell TL
Nat Commun; 2021 Jan; 12(1):143. PubMed ID: 33420031
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies of mycobacterial IspD enzymes.
Björkelid C; Bergfors T; Henriksson LM; Stern AL; Unge T; Mowbray SL; Jones TA
Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):403-14. PubMed ID: 21543842
[TBL] [Abstract][Full Text] [Related]
7. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
8. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
Van Calenbergh S; Pochet S; Munier-Lehmann H
Curr Top Med Chem; 2012; 12(7):694-705. PubMed ID: 22283813
[TBL] [Abstract][Full Text] [Related]
9. Structure-based in-silico rational design of a selective peptide inhibitor for thymidine monophosphate kinase of mycobacterium tuberculosis.
Kumar M; Sharma S; Srinivasan A; Singh TP; Kaur P
J Mol Model; 2011 May; 17(5):1173-82. PubMed ID: 20697760
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and dynamics studies of cytidylate kinase from Mycobacterium tuberculosis H37Rv.
Caceres RA; Macedo Timmers LF; Vivan AL; Schneider CZ; Basso LA; De Azevedo WF; Santos DS
J Mol Model; 2008 May; 14(5):427-34. PubMed ID: 18343960
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis High-Throughput Screening.
White EL; Tower NA; Rasmussen L
Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
13. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Vanheusden V; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
Bioorg Med Chem Lett; 2002 Oct; 12(19):2695-8. PubMed ID: 12217356
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.
Pochet S; Dugué L; Labesse G; Delepierre M; Munier-Lehmann H
Chembiochem; 2003 Aug; 4(8):742-7. PubMed ID: 12898625
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening.
Cho Y; Ioerger TR; Sacchettini JC
J Med Chem; 2008 Oct; 51(19):5984-92. PubMed ID: 18778048
[TBL] [Abstract][Full Text] [Related]
17. Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I.
Ekins S; Godbole AA; Kéri G; Orfi L; Pato J; Bhat RS; Verma R; Bradley EK; Nagaraja V
Tuberculosis (Edinb); 2017 Mar; 103():52-60. PubMed ID: 28237034
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new
Mehra R; Chib R; Munagala G; Yempalla KR; Khan IA; Singh PP; Khan FG; Nargotra A
Mol Divers; 2015 Nov; 19(4):1003-19. PubMed ID: 26232029
[TBL] [Abstract][Full Text] [Related]
19. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
Goldman RC
Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
[TBL] [Abstract][Full Text] [Related]
20. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
